Telesis Bio, Inc.
CFTR MRNA compositions and related methods and uses

Last updated:

Abstract:

The present invention is particularly useful for treating cystic fibrosis. The disclosure concerns method and compositions for treating cystic fibrosis. The method comprises inducing CFTR expression in epithelial cells in a lung of a mammal by contacting the epithelial cells in the lung of the mammal with a composition, where the composition is a pharmaceutical composition comprising in vitro transcribed mRNA.

Status:
Grant
Type:

Utility

Filling date:

16 Jun 2017

Issue date:

24 Sep 2019